CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 200 enrolled
Drug / intervention
Rabeprazole 20 mgdrug
Likely dose
Rabeprazole 20 mg once dailyAI-extracted
Key inclusion· 5
  • ✓Age 18 to 65 years
  • ✓Minimum 3-month history of GERD symptoms (heartburn with or without regurgitation)
  • ✓At least 4 days with heartburn per week in each of the 2 weeks prior to Screening
  • ✓No esophagitis on endoscopy
Key exclusion· 6
  • ✕Evidence of significant hepatic, renal, respiratory, endocrine, hematologic, neurologic, psychiatric, or cardiovascular abnormalities that would interfere with study conduct, results interpretation, or patient health
  • ✕Pregnant, lactating, or positive urine B-hCG
  • ✕History of allergy or sensitivity to proton pump inhibitors or their inactive ingredients
  • ✕History of gastric ulcer, duodenal ulcer, infectious or inflammatory conditions of small or large intestine, malabsorption syndromes, obstruction, GI malignancy, or prior gastric/intestinal surgery including vagotomy

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00165841
NCT00165841Phase 2Completed
CompareCT.gov

A Double-Blind, Placebo-Controlled Study of Rabeprazole 20 mg Maintenance Intermittent Therapy Following Acute Treatment in Patients Wth Symptomatic Gastroesophageal Reflux Disease

Eisai Inc.·interventional·Posted Sep 14, 2005·Updated May 20, 2013

In Brief

A Phase 2 clinical trial evaluating Rabeprazole 20 mg for Gastroesophageal Reflux Disease. Completed, enrolled 200 participants across 1 site.

Detailed Summary

The purpose of this study to determine the efficacy of 20 mg of rabeprazole given as a maintenance intermittent therapy following acute treatment for Symptomatic Gastroesophageal Reflux Disease (s-GERD).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsGastroesophageal Reflux Disease
CountriesUnited States
Collaborators--

Timeline

Phase 2CompletedFinished
20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedSep 14, 2005
Enrollment StartOct 1, 2004
Primary CompletionDec 1, 2005
Study CompletionJun 1, 2008
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 20.8 years ago

Interventions

Rabeprazole 20 mgdrug

rabeprazole sodium tablet 20 mg once daily